We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Studies
Hop3.5
Hops Research
Mostly mechanism / observational
41 peer-reviewed studies
What the evidence says
Mostly mechanism / observational
Most Hops studies are mechanism or observational rather than RCTs that measure a clinical effect — keep findings provisional.
Most evidence is from high-quality meta-analyses and randomised trials published 2004–2026 with a typical study size of 19 participants.
Based on 41 studies · 1 meta-analysis · 35 RCTs · 52 total participants
Confidence
Moderate confidence
By outcome
Sleep & insomniaModestly shorter sleep latency and deeper sleep — but only demonstrated in valerian-hops combinations, not hops alone · Same night to 2 weeks (combination data)
Mostly mechanism / observational4 studies
Anxiety & stressTraditional calming use; direct clinical evidence for standalone hops on anxiety is minimal · Unclear
Too few graded studies2 studies
Active research area
16 studies in the last 5 years · Latest meta-analysis: 2020
200420152026
1Meta-Analysis2020
Kovalchuk I, Pellino M, Rigault P, van Velzen R, Ebersbach J, Ashnest JR · Annu Rev Plant Biol (2020)
In plain English: Continued efforts to enhance its bioavailability and conduct rigorous clinical trials are essential to fully establish its clinical relevance in patient populations.
Azuero M, Wenceslau CF, Tan W. · Nutrients (2026)
Human subject studies demonstrate that XN is safe and well tolerated, with observed reductions in oxidative DNA damage and inflammatory cytokine release.
Recent advances in micellar formulations have improved XN's systemic bioavailability and thus its translational feasibility.
Conclusions In summary, XN is a safe, multifunctional natural compound with strong potential for modulating disease-relevant biological pathways associated with cancer, neurodegenerative diseases, metabolic disorders, and inflammatory skin conditions.
In plain English: The development of delivery systems and consideration of the role of the gut microbiota may further increase its clinical application.
Kogut Ł et al. · Nutrients (2026)
Despite relatively good intestinal absorption, systemic bioavailability remains limited; however, modern delivery systems significantly increase the stability and plasma concentrations of these compounds.
Conclusions: Common hops have broad therapeutic potential due to their ability to regulate oxidative, inflammatory, metabolic and apoptotic processes at multiple levels.
Their pleiotropic activity makes them a promising candidate for the prevention and treatment of chronic diseases.